Violeta Temper

630 total citations
26 papers, 399 citations indexed

About

Violeta Temper is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Violeta Temper has authored 26 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Infectious Diseases and 6 papers in Clinical Biochemistry. Recurrent topics in Violeta Temper's work include Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antifungal resistance and susceptibility (3 papers). Violeta Temper is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antifungal resistance and susceptibility (3 papers). Violeta Temper collaborates with scholars based in Israel, United States and Switzerland. Violeta Temper's co-authors include Colin Block, Allon E. Moses, Carlos Hidalgo‐Grass, Shmuel Benenson, Jacob Strahilevitz, Diana Averbuch, Tzahi Neuman, Johanna Emgård, Markus Gerhard and Ofer N. Gofrit and has published in prestigious journals such as Journal of Clinical Microbiology, The American Journal of Human Genetics and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Violeta Temper

23 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Violeta Temper Israel 12 121 86 75 54 51 26 399
R. P. Smith United Kingdom 14 63 0.5× 72 0.8× 19 0.3× 61 1.1× 54 1.1× 27 374
Valerie P. O’Brien United States 14 443 3.7× 38 0.4× 68 0.9× 35 0.6× 133 2.6× 24 755
KE Hill New Zealand 13 59 0.5× 48 0.6× 21 0.3× 35 0.6× 28 0.5× 36 406
Deborah De Geyter Belgium 13 123 1.0× 98 1.1× 26 0.3× 137 2.5× 70 1.4× 36 502
Laura Bricio-Moreno United Kingdom 13 255 2.1× 55 0.6× 141 1.9× 116 2.1× 22 0.4× 19 716
Ferenc Karpati Sweden 14 85 0.7× 76 0.9× 26 0.3× 45 0.8× 70 1.4× 26 672
Barbara Thompson United States 7 43 0.4× 106 1.2× 23 0.3× 23 0.4× 35 0.7× 9 461
Elaine M. Mokrzan United States 10 100 0.8× 23 0.3× 118 1.6× 26 0.5× 19 0.4× 15 394
Laurie A. Whittaker United States 11 61 0.5× 25 0.3× 18 0.2× 75 1.4× 15 0.3× 14 570
Jean Tyrrell United States 14 42 0.3× 39 0.5× 55 0.7× 19 0.4× 28 0.5× 20 596

Countries citing papers authored by Violeta Temper

Since Specialization
Citations

This map shows the geographic impact of Violeta Temper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Temper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Temper more than expected).

Fields of papers citing papers by Violeta Temper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violeta Temper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Temper. The network helps show where Violeta Temper may publish in the future.

Co-authorship network of co-authors of Violeta Temper

This figure shows the co-authorship network connecting the top 25 collaborators of Violeta Temper. A scholar is included among the top collaborators of Violeta Temper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Violeta Temper. Violeta Temper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marano, R, Yonatan Oster, Yair Motro, et al.. (2025). An Omics-Guided Investigation of a Hospital Outbreak Caused by blaNDM-1-Producing Pseudocitrobacter faecalis. PubMed Central. 232(1). e17–e26. 2 indexed citations
2.
Orenbuch‐Harroch, Efrat, et al.. (2025). Aztreonam-amoxicillin/clavulanate combination therapy against bla NDM-producing Enterobacterales infections. Journal of Antimicrobial Chemotherapy. 80(12). 3375–3380.
3.
Goldstein, Gal, et al.. (2024). Invasive Fungal Infections in Children with Acute Leukemia: Epidemiology, Risk Factors, and Outcome. Microorganisms. 12(1). 145–145. 4 indexed citations
4.
Strahilevitz, Jacob, Yair Motro, Violeta Temper, et al.. (2024). In vivo selection of carbapenem resistance during persistent Klebsiella pneumoniae sequence type 395 bloodstream infection due to OmpK36 deletion. Antimicrobial Agents and Chemotherapy. 68(8). e0066324–e0066324. 1 indexed citations
5.
Avni, Dror, Michal Solomon, Merav Strauss, et al.. (2024). The Epidemiology of PCR-Confirmed Cutaneous Leishmaniasis in Israel: A Nationwide Study. Microorganisms. 12(10). 1950–1950. 1 indexed citations
6.
7.
8.
Averbuch, Diana, et al.. (2022). Bacteremia with Carbapenemase-Producing Enterobacterales in Immunocompromised Patients Colonized with These Bacteria. Microbial Drug Resistance. 28(5). 593–600. 7 indexed citations
9.
Temper, Violeta, et al.. (2020). False-positive galactomannan antigen testing in pulmonary nocardiosis. Medical Mycology. 59(2). 206–209. 6 indexed citations
10.
Gross, Itai, et al.. (2020). Tickborne Relapsing Fever, Jerusalem, Israel, 2004–2018. Emerging infectious diseases. 26(10). 2420–2423. 4 indexed citations
11.
Gur, Chamutal, Naseem Maalouf, Markus Gerhard, et al.. (2019). The Helicobacter pylori HopQ outermembrane protein inhibits immune cell activities. OncoImmunology. 8(4). e1553487–e1553487. 48 indexed citations
12.
Regev‐Yochay, Gili, Yael Paran, Jihad Bishara, et al.. (2015). Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study. Vaccine. 33(9). 1135–1142. 52 indexed citations
13.
Shamriz, Oded, Dan Engelhard, Violeta Temper, et al.. (2015). Infections caused by Fusobacterium in children: a 14-year single-center experience. Infection. 43(6). 663–670. 15 indexed citations
14.
Livovsky, Dan M., David Leibowitz, Carlos Hidalgo‐Grass, et al.. (2012). Bordetella holmesii meningitis in an asplenic patient with systemic lupus erythematosus. Journal of Medical Microbiology. 61(8). 1165–1167. 8 indexed citations
15.
Hidalgo‐Grass, Carlos, Violeta Temper, Shmuel Benenson, et al.. (2012). KPC-9, a Novel Carbapenemase from Clinical Specimens in Israel. Antimicrobial Agents and Chemotherapy. 56(11). 6057–6059. 22 indexed citations
16.
Benenson, Shmuel, et al.. (2011). Imipenem Disc for Detection of KPC Carbapenemase-Producing Enterobacteriaceae in Clinical Practice. Journal of Clinical Microbiology. 49(4). 1617–1620. 13 indexed citations
17.
Rosengarten, Dror, Colin Block, Carlos Hidalgo‐Grass, et al.. (2010). Cluster of Pseudoinfections withBurkholderia cepaciaAssociated with a Contaminated Washer-Disinfector in a Bronchoscopy Unit. Infection Control and Hospital Epidemiology. 31(7). 769–771. 19 indexed citations
18.
Block, Colin, Violeta Temper, Carlos Hidalgo‐Grass, et al.. (2010). An Outbreak of Achromobacter xylosoxidans Associated With Ultrasound Gel Used During Transrectal Ultrasound Guided Prostate Biopsy. The Journal of Urology. 185(1). 144–147. 39 indexed citations
19.
Cahn, Avivit, Benjamin Koslowsky, Ran Nir‐Paz, et al.. (2009). Imported Melioidosis, Israel, 2008. Emerging infectious diseases. 15(11). 1809–1811. 15 indexed citations
20.
Blumenfeld, Anat, Susan A. Slaugenhaupt, Christopher B. Liebert, et al.. (1999). Precise Genetic Mapping and Haplotype Analysis of the Familial Dysautonomia Gene on Human Chromosome 9q31. The American Journal of Human Genetics. 64(4). 1110–1118. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. P. Smith Breakdown of academic impact, for papers by Valerie P. O’Brien Breakdown of academic impact, for papers by KE Hill Breakdown of academic impact, for papers by Deborah De Geyter Breakdown of academic impact, for papers by Laura Bricio-Moreno Breakdown of academic impact, for papers by Ferenc Karpati Breakdown of academic impact, for papers by Barbara Thompson Breakdown of academic impact, for papers by Elaine M. Mokrzan Breakdown of academic impact, for papers by Laurie A. Whittaker Breakdown of academic impact, for papers by Jean Tyrrell
Rankless by CCL
2026